MLN0002

· Takeda

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MLN0002, covering 2019-03-20 to 2019-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease [Phase 3]